Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-21 Purchase |
2024-10-23 7:53 pm |
Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director |
1,460,000 | $1.37 | $2,000,200 | 1,520,000 (Indirect Direct) |
View |
| 2024-10-21 Purchase |
2024-10-23 7:49 pm |
Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director |
145,000 | $1.37 | $198,650 | 205,000 (Direct) |
View |
| 2024-10-21 Purchase |
2024-10-23 7:43 pm |
Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director |
365,000 | $1.37 | $500,050 | 425,000 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-14 Option Award |
2025-04-16 4:06 pm |
N/A 2035-04-14 |
Inhibikase Therapeutics Inc. | IKT | McIntyre David Chief Financial Officer |
1,775,539 | $0 | 1,775,539 (Direct) |
View |
Ownership |
2025-04-16 4:05 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | McIntyre David Chief Financial Officer |
0 | $0 | 10,285 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 4:10 pm |
N/A 2035-02-21 |
Inhibikase Therapeutics Inc. | IKT | Cabell Christopher President & Head of R&D |
1,100,705 | $0 | 1,100,705 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 4:10 pm |
N/A 2035-02-21 |
Inhibikase Therapeutics Inc. | IKT | Aurentz Vincent Director |
134,427 | $0 | 134,427 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 4:05 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Iwicki Mark T Chief Executive Officer |
602,346 | $0 | 602,346 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:26 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Iwicki Mark T Chief Executive Officer |
6,168,148 | $0 | 6,168,148 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:19 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director |
173,185 | $0 | 173,185 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:18 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director |
190,165 | $0 | 190,165 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:16 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
22,640 | $0 | 22,640 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:11 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director |
173,185 | $0 | 173,185 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:11 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Canner David Director |
139,225 | $0 | 139,225 (Direct) |
View |
| 2025-01-21 Option Award(A) |
2025-02-19 8:06 pm |
N/A 2026-08-31 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
68,968 | $0 | 68,968 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:00 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
39,620 | $0 | 39,620 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-22 4:05 pm |
N/A 2029-11-28 |
Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer |
95,834 | $0 | 95,834 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-22 4:05 pm |
N/A 2026-07-28 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
70,106 | $0 | 70,106 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-22 4:05 pm |
N/A 2026-08-31 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
70,106 | $0 | 70,106 (Indirect) |
View |
| 2025-01-21 Option Award |
2025-01-22 4:05 pm |
N/A 2025-11-01 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO |
135,716 | $0 | 135,716 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 6:47 pm |
N/A 2035-01-03 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO |
11,582,471 | $0 | 11,582,471 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 6:43 pm |
N/A 2035-01-03 |
Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer |
1,139,097 | $0 | 1,139,097 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 6:39 pm |
N/A 2035-01-03 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
833,290 | $0 | 833,290 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 6:38 pm |
N/A 2035-01-03 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
833,290 | $0 | 833,290 (Direct) |
View |
Ownership |
2024-10-25 5:52 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | Sands Capital Life Sciences Pulse Fund II L.P. Sands Capital Ventures LLC SANDS FRANK M. 10% Owner |
0 | $0 | 10,950,000 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 7:58 pm |
N/A 2034-10-21 |
Inhibikase Therapeutics Inc. | IKT | Canner David Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 7:53 pm |
N/A 2034-10-21 |
Inhibikase Therapeutics Inc. | IKT | Bellini Roberto Director |
60,000 | $0 | 1,520,000 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 7:49 pm |
N/A 2034-10-21 |
Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director |
60,000 | $0 | 205,000 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 7:43 pm |
N/A 2034-10-21 |
Inhibikase Therapeutics Inc. | IKT | Munshi Amit Director |
60,000 | $0 | 425,000 (Direct) |
View |
| 2024-07-16 Option Award |
2024-07-18 5:27 pm |
N/A 2031-07-16 |
Inhibikase Therapeutics Inc. | IKT | GRINT PAUL C Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-07-16 Option Award |
2024-07-18 5:23 pm |
N/A 2031-07-16 |
Inhibikase Therapeutics Inc. | IKT | Dion Gisele Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-07-16 Option Award |
2024-07-18 5:20 pm |
N/A 2031-07-16 |
Inhibikase Therapeutics Inc. | IKT | BERMAN DENNIS N Director |
30,000 | $0 | 30,000 (Indirect) |
View |
| 2024-07-16 Option Award |
2024-07-18 5:18 pm |
N/A 2031-07-16 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 4:47 pm |
N/A 2031-04-01 |
Inhibikase Therapeutics Inc. | IKT | Werner Milton H. President and CEO 10% Owner |
45,000 | $0 | 45,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-02 5:14 pm |
N/A 2031-04-01 |
Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2024-04-02 5:12 pm |
N/A 2029-11-28 |
Inhibikase Therapeutics Inc. | IKT | Lees-Rolfe Garth Chief Financial Officer |
0 | $0 | 5,834 (Direct) |
View |